Israel Englander Monopar Therapeutics Put Options Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding MNPR
# of Institutions
13Shares Held
418KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA60KShares$406,4430.0% of portfolio
-
Two Sigma Securities, LLC New York, NY47.1KShares$318,5820.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA45.2KShares$305,7800.0% of portfolio
-
Gerber, LLC Columbus, OH28KShares$189,5930.02% of portfolio
-
Virtu Financial LLC New York, NY18.8KShares$127,5460.0% of portfolio
About Monopar Therapeutics
- Ticker MNPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,725,800
- Market Cap $86.2M
- Description
- Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. Its lead product candidate in development is Validive, a clonidine hydrochloride mucobuccal tablet that is in Phase 2b/3 clinical trial for the prevention of chemoradiotherapy induced severe ...